Related Experiment Videos
Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma
Ryota Tanaka1, Tadashi Ishiyama, Teruhito Uchihara
1Department of Thoracic Surgery, Gunma Prefectural Cancer Center, Gunma, and Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Ibaraki, Japan.
Background:
The regulation of programmed cell death, or apoptosis, is crucial for normal development and for the maintenance of homeostasis. It has been shown that the novel antiapoptotic protein Bax inhibitor-1 (BI-1) represents a new type of regulator of cell death pathways controlled by Bcl-2 and Bax.
Methods:
Surgically resected lung specimens were obtained from 32 patients with peripheral adenocarcinomas, and BI-1 gene expression was examined and compared with expression of the p53, bcl-2 and Bax genes.
Results:
Fourteen of 32 tumors (43.8%) were positive for BI-1 gene expression by in situ hybridization. BI-1 gene expression in tumor specimens was significantly higher in adenocarcinomas with bronchioloalveolar carcinoma (BAC) and in adenocarcinomas of mixed subtypes with bronchioloalveolar spreading (14 of 17 tumors; 82.4%) than in carcinomas without it spreading. Patients who had BI-1-positive adenocarcinoma showed a relatively favorable prognosis compared with patients who had BI-1-negative adenocarcinoma. Eleven of 32 tumors (34.4%) were positive for the p53 protein, only 1 of 32 tumors (3.1%) was positive for the Bcl-2 protein, and 26 of 32 tumors (81.3%) were positive for the Bax protein. Protein expressions of p53, Bcl-2, and Bax, as detected by immunohistochemistry, were not associated with BI-1 gene expression.
Conclusions:
BI-1 gene expression was restricted to tumor cells with lepidic growth and was a prognostic factor for peripheral-type adenocarcinoma. It is believed that BI-1 gene expression is conserved evolutionarily and may act as a key regulator of the apoptotic pathway in BAC.
Insights
Bax inhibitor-1 (BI-1) gene expression in lung adenocarcinoma, particularly with bronchioloalveolar carcinoma features, indicates a favorable prognosis. BI-1 acts as a key regulator in the apoptotic pathway, offering insights into cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Apoptosis regulation is vital for development and homeostasis.
- Bax inhibitor-1 (BI-1) is a novel antiapoptotic protein regulating cell death pathways involving Bcl-2 and Bax.
- Understanding BI-1's role in cancer is crucial for therapeutic development.
Purpose of the Study:
- To investigate BI-1 gene expression in peripheral lung adenocarcinomas.
- To compare BI-1 expression with p53, Bcl-2, and Bax gene expression.
- To determine the prognostic significance of BI-1 in lung adenocarcinoma.
Main Methods:
- Analysis of surgically resected lung adenocarcinoma specimens from 32 patients.
- In situ hybridization to examine BI-1 gene expression.
- Immunohistochemistry to assess p53, Bcl-2, and Bax protein expression.
Main Results:
- BI-1 gene expression was detected in 43.8% of tumors.
- Higher BI-1 expression was observed in adenocarcinomas with bronchioloalveolar carcinoma (BAC) components (82.4%).
- BI-1-positive tumors correlated with a more favorable prognosis; p53, Bcl-2, and Bax protein levels were not associated with BI-1 expression.
Conclusions:
- BI-1 gene expression is linked to lepidic growth and serves as a prognostic factor in peripheral lung adenocarcinoma.
- BI-1 may function as a critical regulator of the apoptotic pathway, especially in BAC.
- Further research into BI-1's evolutionary conservation and regulatory mechanisms is warranted.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
02:23Abnormal Proliferation